SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 15, 2023 - (NASDAQ: DMTK)
NEW YORK, Nov. 7, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DermTech, Inc..
Shareholders who purchased shares of DMTK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/dermtech-loss-submission-form/?id=54813&from=4
CLASS PERIOD: May 3, 2022 to November 3, 2022
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company experienced challenges with collections from commercial payors; (2) as a result, there was a lower average selling price for the DermTech Melanoma Test; (3) as a result of the foregoing, the Company's revenue growth would be adversely impacted; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
DEADLINE: December 15, 2023 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/dermtech-loss-submission-form/?id=54813&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of DMTK during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is December 15, 2023. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
SOURCE The Gross Law Firm
Ausgewählte Hebelprodukte auf DermTech International Registered
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DermTech International Registered
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle DermTech International Registered Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
DermTech International Registered Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DermTech International Registered nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.